AwarePoint

AwarePoint raised $100.9M from top-tier investors like Kleiner Perkins to track medical devices in hospitals using RFID technology. ​​‌‌‌‌‌‌‌​‌‌​​‌​​​​​​‌‌​‌‌‌​​​‌‌Early signals seemed promising: hospital administrators expressed frustration about lost equipment costing them millions annually. The company measured interest through pilot programs at major medical centers, where staff initially engaged with the tracking system. First-year adoption showed hospitals purchasing hardware and licensing software, suggesting genuine demand. However, AwarePoint confused stated problems with actual purchasing behavior. Hospitals wanted the *problem solved*, not necessarily this solution. When implementation required workflow changes and staff retraining, adoption stalled. The company missed critical warning signs: pilots succeeded only with heavy vendor support, hospitals delayed full rollouts indefinitely, and IT departments resisted integration complexity. AwarePoint had validated that the problem existed, not that customers would pay for *this* fix. The company eventually sold assets at a fraction of its valuation, proving that behavioral signals from controlled pilots don't guarantee market demand when real-world friction emerges.